Roadway to the Brain? Alzheimer’s Linked to Notorious Tire Chemical

A chemical that sheds off car tires and washes into streams already carries a grim reputation, blamed for wiping out coho salmon across the Pacific Northwest. A team of researchers has now asked a harder question: could that same tire chemical have anything to do with Alzheimer’s disease?

Their answer, published in the journal Open Medicine, is careful but hard to ignore. Working entirely with computer models rather than lab dishes or live animals, researchers say the tire compound looks able to latch onto several proteins tied to Alzheimer’s. Nobody has shown the chemical causes the disease. What the study offers is a map of where scientists might look next.

That gap between “linked” and “caused” is the whole story here. Alzheimer’s affects roughly 55 million people worldwide and still has no cure, and researchers have spent years hunting for triggers beyond genetics. An emerging pollutant that can slip into the brain is exactly the sort of suspect worth examining, well before anyone can call it guilty.

What Is the Tire Chemical 6PPD-Quinone?

Car tires contain an additive called 6PPD, which keeps rubber from cracking. When 6PPD reacts with ozone in the air, it forms a byproduct known as 6PPD-quinone (6PPD-Q). Rain then rinses it off roads and into waterways. Around 2020, scientists identified it as the cause of sudden salmon die-offs after storms, putting the compound on regulators’ radar.

Since then, researchers have detected 6PPD-Q in road dust, rivers, and even human urine, blood, and spinal fluid. Animal work adds a worrying detail: in mice, the compound can cross the blood-brain barrier within half an hour. In other words, it can reach the organ Alzheimer’s attacks. Almost nothing is known about what it does once it gets there, which is the blank space this paper tries to sketch in.

Linking 6PPD-Q to Alzheimer’s in the Lab

No patients were dosed and no animals were exposed for this study. Instead, the authors ran a stack of computational methods and then cross-checked the results against existing datasets from other labs.

First, they used a technique that maps which human proteins the chemical is likely to interact with, then compared that list against genes already known to be important in Alzheimer’s. That overlap totaled 92 shared targets. Narrowing further, they landed on 23 “core” proteins, with three standing out: NFKB1, GSK3B, and PIK3CA. When they checked where those proteins are most active in the body, the signal pointed straight at brain regions involved in the disease.

Next came a reality check against real tissue. Researchers pulled gene-activity data from postmortem brains, one set covering 12 Alzheimer’s patients alongside 10 older and 8 younger comparison brains, another comparing 44 patients with 46 controls. Several of the flagged proteins behaved differently in diseased brains. A machine-learning step then ranked which proteins best separated Alzheimer’s cases from healthy ones, and a genetics-based test, run against data from nearly 490,000 people, supported a possible causal thread between one protein, NFKB1, and Alzheimer’s risk.

What the Computer Models Actually Found

For the finale, the researchers simulated whether 6PPD-Q physically fits into these proteins, a bit like testing a key against a set of locks. Several fits looked snug, especially with a protein called PTGS2, a known marker of inflammation. Put together, the picture the authors sketch is a chemical that could stir up oxidative stress and inflammation in the brain and jam the signaling that keeps brain cells talking to one another, damage that tends to converge on failing connections between neurons.

Here’s the catch worth sitting with: a chemical fitting into a protein on a screen does not prove it harms that protein in a living brain. The authors say as much, and one of their own results shows why caution is earned. For NFKB1, the protein that scored the strongest genetic link, the data hint it might actually protect healthy neurons rather than damage them. Biology rarely reads as a clean villain story.

Why This Tire Chemical–Alzheimer’s Link Comes With Major Caveats

Researchers are upfront that “several limitations should be acknowledged.” Their whole analysis rests on predictions, not wet-lab proof, so as they put it, “Experimental validation is therefore required” before anyone leans on these results. The brain samples they borrowed came from late-stage Alzheimer’s patients and were never measured for tire-chemical exposure, so they cannot show that 6PPD-Q did anything to those specific brains. The smallest dataset held just 12 patients. And late-stage tissue can bury the early changes that a pollutant might trigger years earlier.

None of that makes the work pointless. It makes it a starting flag. By naming specific proteins and specific brain regions, the study hands the next research team a shortlist instead of a blank page. Whether a chemical rinsing off the world’s roads belongs on the list of Alzheimer’s risks is still an open question, but it is now a question with an address.

Disclaimer: This report summarizes findings from one peer‑reviewed study and is intended for general information only. The research relied entirely on computer models and reused datasets and did not test patients or animals, so it cannot show that the tire chemical 6PPD‑quinone causes Alzheimer’s disease or any other condition. The study authors themselves note multiple limitations and call for further laboratory and animal research before drawing firm conclusions. Nothing in this article should be taken as medical advice or as definitive evidence that exposure to any specific chemical will lead to Alzheimer’s; readers should consult qualified health professionals for personal medical guidance.

---